Search the Newsreel

FMR LLC discloses 5.7% Amphenol (APH) stake held through affiliated entities

FMR LLC reported a 5.7% beneficial ownership stake in Amphenol Corporation's Class A common stock, totaling 70,486,300.18 shares as of June 30, 2026, via an Amendment No. 27 to a Schedule 13G filing. Abigail P. Johnson is also reported with the same beneficial ownership, …

Enovis reaffirms 2026 outlook and targets >25% free cash flow conversion as Arvis rollout expands

Earnings Call Insights: Enovis (ENOV) Q2 2026 MANAGEMENT VIEW * CEO Damien McDonald said Q2 results showed “the strength and stability of our diversified product portfolio” and reported “organic growth of 5%, driven by 6% organic growth in Recon and 3% organic growth in …

10x Genomics raises 2026 revenue outlook to $610M-$630M as Atera shipments remain about 40 units

Earnings Call Insights: 10x Genomics (TXG) Q2 2026 MANAGEMENT VIEW * "Revenue for the second quarter was $151 million" (CEO Serge Saxonov) and management highlighted a nonrecurring item: "we recognized $1.6 million of license and royalty revenue in connection with our settlement with Takara" …

Edding Genor Advances GB268 Breast Cancer Trial with First Patient Dosed

Cenovus Energy (TSX:CVE) Lifts Guidance Following Strong Results With Valuation Back In Focus

Cenovus Energy recently reported strong second-quarter 2026 results, showing higher sales, net income, and upstream production, alongside updated guidance and capital returns through dividends and share buybacks. Despite a significant year-to-date share price increase of 64.70% and a five-year return of 326.13%, the company …

Enovis Backs 2026 Guidance >ENOV

Enovis is reaffirming its financial guidance for 2026. The company anticipates achieving $2.5 billion in revenue and an adjusted EBITDA margin of 23% by that year. This reiteration suggests confidence in their ongoing business strategies and growth trajectory.

Xenon Reports Q2 2026 Financial Results and Provides Business Update

Xenon Pharmaceuticals Inc. announced its Q2 2026 financial results, highlighted by the continued progress of its lead drug azetukalner, with an NDA submission for FOS on track for Q3 2026 and Phase 3 data for MDD expected in H1 2027. The company reported $1.2 …

10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations

10x Genomics (NASDAQ: TXG) grows consumables, ends Q2 with $502M cash

10x Genomics reported a Q2 2026 total revenue of $151.0M, a 13% decrease from Q2 2025, primarily due to the absence of large, non-recurring patent-license settlements from the previous year. Despite this, underlying products and services revenue grew by 3% to $149.1M, driven by …

10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Terreno Realty Corporation (TRNO) stock price, news, quote and history

Terreno Realty Corporation (TRNO) is an acquirer, owner, and operator of industrial real estate in six major coastal U.S. markets. The company recently executed new renewal leases totaling 233,000 square feet at Countyline Corporate Park Phase III in Hialeah, Florida. Terreno's stock closed at …

RenovoRx’s RenovoCath used in sarcoma treatment for first time By Investing.com

RenovoRx Inc. announced that its RenovoCath drug-delivery device was used commercially for the first time to treat a sarcoma patient at CARTI Cancer Center. This marks an expansion beyond the company's prior focus on pancreatic cancer, demonstrating the device's potential for local chemotherapy delivery …

10X GENOMICS ($TXG) Releases Q2 2026 Earnings

Earnings Flash (XENE) Xenon Pharmaceuticals Inc. Reports Q2 Revenue $0

Earnings call transcript: Enovis tops Q2 2026 EPS view but shares fall 6.7%

10x Genomics (NASDAQ: TXG) swings to Q2 loss but lifts 2026 revenue guide

10x Genomics Reports Second Quarter 2026 Financial Results

Why Enovis (ENOV) Shares Are Sliding Today

Enovis Corporation's shares fell 12.8% after reporting second-quarter earnings, despite revenue and adjusted earnings surpassing Wall Street expectations. The decline was attributed to a weaker full-year earnings per share outlook and a significant contraction in the company's adjusted operating margin, which fell 6.7 percentage …

Amphenol (APH) sube un 14,6 % tras superar las previsiones de ventas impulsadas por la IA, una división de acciones y un aumento del dividendo: ¿ha cambiado el panorama alcista?

Xenon Pharmaceuticals earnings on deck as FDA approval push nears

Xenon Pharmaceuticals is set to release its second-quarter earnings, with investors keenly watching its cash position and regulatory timeline as it approaches an FDA submission for its drug, azetukalner. Analysts anticipate a loss of $1.14 per share on $1.5 million in revenue. The company …

Amphenol (APH) Is Up 14.6% After AI-Fueled Sales Beat, Stock Split And Dividend Hike - Has The Bull Case Changed?

Kenon Holdings Ltd (76N.DU) cash flow

This article provides detailed cash flow statements for Kenon Holdings Ltd (76N.DU), covering annual and quarterly data up to December 31, 2025. It includes figures for operating, investing, and financing cash flows, capital expenditure, debt issuance and repayment, stock repurchase, and free cash flow. …

Enovis CORP 2026: Revenue $582.78M, EPS ($0.02) — 10-Q Summary

Enovis CORP (ENOV) reported its 2026 Q3 results, showing a revenue of $582.78M, a 3.2% increase year-over-year. The company significantly reduced its net loss to ($1.19M) from ($36.74M) in the prior-year quarter, with diluted EPS improving to ($0.02) from ($0.64). This performance was driven …

FMR LLC and Abigail Johnson report 9.9% Xenon Pharmaceuticals (XENE) holding

FMR LLC and Abigail Johnson have reported a 9.9% beneficial ownership stake in Xenon Pharmaceuticals Inc. (XENE) as of June 30, 2026. FMR LLC holds 9,599,498 common shares with sole dispositive power and sole voting power over 9,591,437 shares, while Abigail P. Johnson also …

Cenovus Energy Inc. stock rises Thursday, outperforms market

Cenovus Energy Inc. (CVE) saw its stock rally by 2.04% to C$39.61 on Thursday, outperforming the broader Canadian market. The S&P/TSX Composite Index fell by 0.03%, while Cenovus Energy Inc. closed 10.2% below its 52-week high.

ServiceNow Stock (NOW) Opinions on Q2 Earnings and AI Growth

Enovis (NYSE:ENOV) Posts Q2 CY2026 Sales In Line With Estimates

Enovis (NYSE:ENOV) reported Q2 CY2026 sales of $582.8 million, meeting Wall Street estimates, with non-GAAP profit exceeding consensus by 6.3% at $0.90 per share. The company reaffirmed its full-year revenue and Adjusted EPS guidance. While long-term revenue growth has been a challenge, recent two-year …

GCM Grosvenor (GCMG) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

In its upcoming report, GCM Grosvenor Inc. (GCMG) is predicted by Wall Street analysts to post quarterly earnings of $0.19 per share, reflecting an increase of 18.8% compared to the same period last year. Revenues are forecasted to be $133.84 million, representing a year-over-year …

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

RenovoRx, Inc. announced the first commercial clinical use of its FDA-cleared RenovoCath device for drug delivery in treating a sarcoma patient at the CARTI Cancer Center. This milestone demonstrates the potential for RenovoCath to expand beyond pancreatic cancer to other solid tumors for localized …

Tenon Medical targets Nasdaq's $1 minimum with a 1-for-35 split

Tenon Medical (NASDAQ: TNON) has announced a 1-for-35 reverse stock split, effective August 10, 2026, to meet Nasdaq's minimum $1.00 average closing price requirement for continued listing. The split will convert 35 pre-split shares into one post-split share, with fractional shares rounded up. Shareholders …

Tenon Medical announces 1-for-35 reverse stock split By Investing.com

Tenon Medical, Inc. has announced a 1-for-35 reverse stock split of its common stock, effective August 10, 2026, before trading begins on the Nasdaq Capital Market. The primary goal of this action is to increase the per share market price to meet Nasdaq's minimum …

Amphenol Board Approves Stock Split; Announces Q3 Adj. EPS Guidance Following Stock Split

(RTTNews) - Amphenol (APH) announced that its Board approved a two-for-one stock split to be paid in the form of a stock dividend. Each Amphenol shareholder of record at the close of business on August 17, 2026 will receive one additional share for every …

A Sarcoma Patient Is Receiving Local Chemotherapy via RenovoCath

RenovoRx (Nasdaq: RNXT) announced the first commercial clinical use of its RenovoCath device for localized chemotherapy delivery in a sarcoma patient at CARTI Cancer Center. This marks an expansion of the device's application beyond pancreatic cancer, demonstrating its potential for treating other solid tumors …

Brazil AI training program to offer 600 seats through ServiceNow partnership

ServiceNow has opened its first dedicated office in Brazil and expanded academic partnerships to build an AI-ready workforce in the region. The company is collaborating with institutions like Porto Digital to offer comprehensive training, including a program that will provide 600 seats for AI …

Amphenol Announces Two-for-One Stock Split and Third Quarter 2026 Dividend

WALLINGFORD, Conn., August 06, 2026--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) today announced that at its meeting held on August 5, 2026, the Company's Board of Directors approved a two-for-one stock split to be paid in the form of a stock dividend. Each Amphenol shareholder of …

Terreno Realty (NYSE:TRNO) Announces Quarterly Earnings Results, Beats Expectations By $0.13 EPS

Terreno Realty (NYSE:TRNO) announced its quarterly earnings, reporting an EPS of $0.54, which surpassed the consensus estimate of $0.41 by $0.13. Despite beating earnings expectations, the company's revenue of $124.71 million fell short of the $127.17 million estimate, and its shares declined 1.1% to …